Drug shows promise in 1st COVID
study of largely minority patients
|
A drug company
said Friday that a medicine it sells to tamp down inflammation has helped
prevent the need for breathing machines in hospitalized COVID-19 patients in
the first large study that primarily enrolled Hispanics and Blacks. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Monday, September 21, 2020
Drug shows promise in 1st COVID study of largely minority patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment